Skip to content
★ Sign in to follow
RM

Robert Mashal

Executive
Insider activity · 24 months2 buys0 salesCumulative net flow
Total declarations
4
Company
1
▲ Purchases (4 ops.)
€355k
▼ Sales (0 ops.)
—

Latest filing published 03 Apr 2025 for Nuvation Bio Inc., €153k.

Filing timeline

BuySale
Robert Mashal

Insider track record

Disclosed buys
4
Disclosed sells
0
Signal history

Closed purchases

Market purchases
4
Positive at T+90
100%
Median T+90
+24.2%

Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 03 Apr 2025 · 585 days ago · €153k
    +168.1%
    Entry US$1.66 · Close at T+365 US$4.45
  • Filed 10 Oct 2024 · 760 days ago · €200k
    +62.1%
    Entry US$2.27 · Close at T+365 US$3.68

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Robert Mashal: trading record in brief

Robert Mashal appears in our data through filings on Nuvation Bio Inc. shares, published by SEC (Form 4). Between 8 October 2024 and 1 April 2025, the trades on record add up to 4 filings.

Every open-market trade on record is a purchase: 4 purchases worth €355k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2025, the count stands at 2 purchases and no sales.

A typical purchase (the median) is worth €77k. The 4 purchases reviewed show no overlap with other insiders buying the same stock within a month. Ninety days after publication, 4 purchases show a median change of +24.2%, with the price up in 100% of them. These figures describe past trades and do not predict future prices.

The record was last updated on 3 April 2025 with an open-market purchase (€153k) in Nuvation Bio Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Robert Mashal

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ▲
    DirectorExecutivesNuvation Bio Inc.
    165,163 USD19SEC
    98,900 shares@ US$1.6743.1% of flowClass A Common StockSEC:0001415889-25-009908:1
    Canonical exit: 30 Jun 2025 (T+90)
  • ▲
    DirectorExecutivesNuvation Bio Inc.
    1,832 USD21SEC
    1,100 shares@ US$1.665597.8% of flowClass A Common StockSEC:0001415889-25-009908:0
    Canonical exit: 30 Jun 2025 (T+90)
  • ▲
    DirectorExecutivesNuvation Bio Inc.
    219,958 USD17SEC
    99,981 shares@ US$2.2056.4% of flowClass A Common StockSEC:0001415889-24-024982:1
    Canonical exit: 6 Jan 2025 (T+90)
  • ▲
    DirectorExecutivesNuvation Bio Inc.
    42 USD11SEC
    19 shares@ US$2.1952.2% of flowClass A Common StockSEC:0001415889-24-024982:0
    Canonical exit: 6 Jan 2025 (T+90)

4 of 4 declarations